T-cell receptor specific for tetanus toxoid–MHC class II complex (TCR-TT-MHCII)

The T-cell receptor (TCR) specific for tetanus toxoid–MHC class II complex is a heterodimeric surface receptor found on CD4+ T helper cells that recognizes processed peptides of the tetanus toxin presented by Major Histocompatibility Complex (MHC) class II molecules (Lanzavecchia et al., 1988). This specific TCR is central to the adaptive immune response against Clostridium tetani, as its activation triggers the expansion of T helper cells that facilitate B-cell antibody production and the establishment of long-term immunity (Demotz et al., 1989). Tetanus toxoid (TT) serves as the primary exogenous ligand in the form of a vaccine, which is designed to prime these receptors and generate memory T cells (CDC, 2023). In clinical research, these receptors are frequently used as models to study T-cell kinetics and the effectiveness of conjugate vaccines where TT acts as a carrier protein to enhance immunogenicity (Pollard et al., 2009). While not a target for traditional inhibitory drugs, the signaling pathways downstream of this TCR are modulated by immunosuppressants like cyclosporine to prevent overactive immune responses (StatPearls, 2023). The interaction between the TCR and the TT-MHCII complex is characterized by high specificity, often targeting immunodominant epitopes such as P2 or P30 (Valmori et al., 1992). Monitoring the frequency and activation state of these TCR-bearing cells provides a biomarker for vaccine efficacy and individual immune competence (NIH, 2022).

Other names

Tetanus toxoid-specific T-cell receptorTT-specific TCRCD4+ T-cell receptor for tetanus toxoidT-cell receptor alpha/beta specific for tetanus toxoid

Antigen-specific recognition of peptide-MHC complexes leading to T-cell receptor signaling, phosphorylation of ITAMs by Lck, and subsequent activation of the NFAT, NF-kappaB, and AP-1 pathways.